Kristin M. Leiferman, MD

Professor of Dermatology and Co-Director of the Immunodermatology Laboratory, University of Utah School of Medicine

Specialties

• Dermatology
• Immunodermatology

Education

• Medical Degree—Mayo Medical School
• Residency—Dermatology, Mayo Clinic
• Research—Immunodermatology, Mayo Clinic

Certifications/Affiliations

• American Board of Dermatology (Dermatology and Dermatological Immunology/Diagnostic and Laboratory Immunology Immunology)

Research Interests

• Immune-mediated (humoral) cutaneous diseases, including immunobullous diseases
• Eosinophil-related inflammation in epithelial tissues
• Allergic inflammation in epithelial tissues, including IgE, mast cell, and basophil-related

Awards

• Best Doctors in America 2001
• Who’s Who in America 2003
• National Institutes of Health Grant Awards

Recent Publications

• Saffari H, et al. Oral administration of 99m technetium-labeled heparin in eosinophilic esophagitis. Mayo Clin Proc. 2020 Mar;95(3):449–58.
• Peterson KA, et al. Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts. Dis Esophagus. 2019 Dec 30;32(11):doz055.
• Khoury P, et al. Revisiting the NIH taskforce on the research needs of eosinophil-associated diseases (RE TREAD). J Leukoc Biol. 2018 Jul;104(1):69–83.
• Saffari H, et al. A subset of patients with pemphigoid (herpes) gestationis has serological evidence of celiac disease. Int J Dermatol. 2018 May;57(5):534–40.
• Leiferman KM, Peters MS. Eosinophil-related disease and the skin. J Allergy Clin Immunol Pract.2018 Sep-Oct;6(5):1462–1482.e6.
• Leiferman KM. Eosinophil-associated diseases with dermatologic manifestations. In: Callen JP, Jorizzo JL, eds. Dermatological Signs of Systemic Disease. Elsevier; 2017:69–76.
• Leiferman KM, Peters MS. Eosinophil-associated dermatoses. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. Elsevier; 2017:440–5.
• Braunberger T, et al. Esophagitis dissecans superficialis endoscopically induced in a patient with pemphigus vulgaris and gastrointestinal complaints. JAMA Dermatol. 2016 Aug 1;152(8):948–50.
• Saffari H, et al. Measurement of inflammation in eosinophilic esophagitis using an eosinophil peroxidase assay. Am J Gastroenterol. 2016 Jul;111(7):933–9.
• Clark JJ, et al. The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: retrospective chart review. J Am Acad Dermatol. 2016 Jun;74(6):1274–6.
• Wright BL, et al. Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia. J Allergy Clin Immunol Pract. 2016 Mar-Ar;4(2):336–7.
• Metcalfe DD, et al. Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases. World Allergy Organ J. 2016 Feb 11;9:7.
• Peterson KA, et al. Extracellular eosinophil granule protein deposition in ringed esophagus with sparse eosinophils. Dig Dis Sci. 2015 Sep;60(9):2646–53.
• Leiferman KM. Epidemiology and pathogenesis of bullous pemphigoid and mucous membrane pemphigoid. In: Zone JJ, Ofori AO, eds. UpToDate Philadelphia. Wolters Kluwer Health;2012 (yearly updates).
• Leiferman KM. Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid. In: Zone JJ, Ofori AO, eds. UpToDate Philadelphia. Wolters Kluwer Health; 2012 (yearly updates).